BackAvecho Biotechnology Limited Overview

Avecho Biotechnology Limited Accounts Payable

Latest accounts payable for AVEFF: $930K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$930381.00
↑ 40.76% YoYΔ $269401.00 vs prior year quarter

Peer trimmed avg / median

Loading

Avecho Biotechnology Limited Accounts Payable History

Loading

Avecho Biotechnology Limited vs. peers: Accounts Payable Comparison

Loading

Avecho Biotechnology Limited Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Avecho Biotechnology Limited (AVEFF) FAQ

As of the most recent data (June 2026), AVEFF shows a accounts payable of $930K. That compares with $660K in the prior-year period — up 40.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVEFF's accounts payable is now $930K (was $660K) — a 40.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Avecho Biotechnology Limited is outperforming or lagging.

Tracking AVEFF's accounts payable over time shows whether Avecho Biotechnology Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $930K That compares with $660K in the prior-year period — up 40.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Avecho Biotechnology Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $930K) with ownership activity and broader fundamentals.

Avecho Biotechnology Limited's accounts payable is $930K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.